Showing the single result

  • Takhzyro lanadelumab
    In Stock
    Add to Wishlist
    Compare
    Quick View

    Buy Takhzyro (lanadelumab) Online For Sale

    $13,774.95

    DISEASE INDICATIONS: Hereditary angioedema (HAE)

    MANUFACTURER: Shire Pharmaceuticals

    USAGE: Subcutaneous

    MEDICINE APPROVED BY:

    European Medical Agency (EMA)

    Food and Drug Administration (FDA)

    Takhzyro is a prescription medication used to prevent swelling caused by hereditary angioedema (HAE) in individuals aged 12 years and older. It works by blocking kallikrein, a protease involved in the pathophysiology of HAE.

    Select options This product has multiple variants. The options may be chosen on the product page